Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elda Grabocka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancer Discovery|February 6, 2023
A Splendid New Beginning at the End of a 40-Year Quest: The First KRASG12D Inhibitor in Pancreatic CancerAlexandra Redding, Elda Grabocka
Trends in Cancer|September 13, 2023
Stress granules and hormetic adaptation of cancerAlexandra Redding, Elda Grabocka
Cancer Cell|August 4, 2009
Raf-1 and squamous cell carcinoma: Rok-ing the boatElda Grabocka, Dafna Bar-Sagi
Oncogene|March 1, 2005
Functional consequences of G alpha 13 mutations that disrupt interaction with p115RhoGEFElda Grabocka, Philip B Wedegaertner
Molecular Pharmacology|July 5, 2007
Disruption of oligomerization induces nucleocytoplasmic shuttling of leukemia-associated rho Guanine-nucleotide exchange factorElda Grabocka, Philip B Wedegaertner
Cell|December 17, 2016
Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress GranulesElda Grabocka, Dafna Bar-Sagi
Reviews of Physiology, Biochemistry and Pharmacology|August 14, 2020
Stress Granules in CancerMin-Seok Song, Elda Grabocka
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2018
Evaluating Stress Granules in Pancreatic Cancer In Vitro and In VivoEdward Sim, Elena Irollo, Elda Grabocka
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage responseElda Grabocka, Cosimo Commisso, Dafna Bar-Sagi
Disease Models & Mechanisms|February 11, 2022
RAS-mediated tumor stress adaptation and the targeting opportunities it presentsAlexandra Redding, Andrew E Aplin, Elda Grabocka
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancer Discovery|February 6, 2023
A Splendid New Beginning at the End of a 40-Year Quest: The First KRASG12D Inhibitor in Pancreatic CancerAlexandra Redding, Elda Grabocka
Trends in Cancer|September 13, 2023
Stress granules and hormetic adaptation of cancerAlexandra Redding, Elda Grabocka
Cancer Cell|August 4, 2009
Raf-1 and squamous cell carcinoma: Rok-ing the boatElda Grabocka, Dafna Bar-Sagi
Oncogene|March 1, 2005
Functional consequences of G alpha 13 mutations that disrupt interaction with p115RhoGEFElda Grabocka, Philip B Wedegaertner
Molecular Pharmacology|July 5, 2007
Disruption of oligomerization induces nucleocytoplasmic shuttling of leukemia-associated rho Guanine-nucleotide exchange factorElda Grabocka, Philip B Wedegaertner
Cell|December 17, 2016
Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress GranulesElda Grabocka, Dafna Bar-Sagi
Reviews of Physiology, Biochemistry and Pharmacology|August 14, 2020
Stress Granules in CancerMin-Seok Song, Elda Grabocka
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2018
Evaluating Stress Granules in Pancreatic Cancer In Vitro and In VivoEdward Sim, Elena Irollo, Elda Grabocka
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Molecular pathways: targeting the dependence of mutant RAS cancers on the DNA damage responseElda Grabocka, Cosimo Commisso, Dafna Bar-Sagi
Disease Models & Mechanisms|February 11, 2022
RAS-mediated tumor stress adaptation and the targeting opportunities it presentsAlexandra Redding, Andrew E Aplin, Elda Grabocka
Pageof 2